Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice

被引:0
|
作者
Maki Nakayama
Norio Abiru
Hiroaki Moriyama
Naru Babaya
Edwin Liu
Dongmei Miao
Liping Yu
Dale R. Wegmann
John C. Hutton
John F. Elliott
George S. Eisenbarth
机构
[1] University of Colorado Health Sciences Center,Barbara Davis Center for Childhood Diabetes
[2] Nagasaki University,Graduate School of Biomedical Sciences
[3] Kobe University Graduate School of Medicine,undefined
[4] University of Alberta,undefined
来源
Nature | 2005年 / 435卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Autoimmune reactions, in which the body's white blood cells harm its own tissues, cause many diseases including diabetes, multiple sclerosis and arthritis. It is not known why immune cells target certain organs, and in particular for childhood diabetes, why only insulin-producing cells are killed. Nakayama et al. now report that this may be because insulin itself is a primary autoantigen for autoimmune diabetes. In NOD mice, the standard animal model for diabetes, when the part of the insulin molecule that gives rise to autoantibodies is altered, autoimmune diabetes disappears. This also suggests that deletional immune therapy could be a practical proposition. The possible clinical relevance of this work is confirmed by a separate study by Kent et al. of human patients with type 1 diabetes. T lymphocytes found in the draining lymph nodes around the pancreas specifically recognize part of the insulin protein. This has implications for antigen specific therapies and islet-cell transplantation in diabetes.
引用
收藏
页码:220 / 223
页数:3
相关论文
共 50 条
  • [21] Role of Hybrid Insulin Peptides in the Development of Type 1 Diabetes
    Delong, Thomas
    Hohenstein, Anita
    Elso, Colleen
    Mannering, Stuart
    DIABETES, 2017, 66 : A668 - A668
  • [22] CD70 Modulates Thymocyte Development and Type 1 Diabetes in NOD Mice
    Ye, Cheng
    Driver, John
    Wiles, Michael V.
    Serreze, Dave
    DIABETES, 2018, 67
  • [23] IRAK-M Deficiency Promotes the Development of Type 1 Diabetes in NOD Mice
    Tan, Qiyuan
    Majewska-Szczepanik, Monika
    Zhang, Xiaojun
    Szczepanik, Marian
    Zhou, Zhiguang
    Wong, F. Susan
    Wen, Li
    DIABETES, 2014, 63 (08) : 2761 - 2775
  • [24] The effect of CXCL10 neutralization in the development of type 1 diabetes in NOD mice
    Okubo, Y
    Morimoto, J
    Yoneyama, H
    Shigihara, T
    Yamada, S
    Oikawa, Y
    Kanazawa, Y
    Narumi, S
    Matsushima, K
    Shimada, A
    DIABETES, 2005, 54 : A25 - A25
  • [25] Replacing murine insulin 1 with human insulin protects NOD mice from diabetes
    Elso, Colleen M.
    Scott, Nicholas A.
    Mariana, Lina
    Masterman, Emma, I
    Sutherland, Andrew P. R.
    Thomas, Helen E.
    Mannering, Stuart, I
    PLOS ONE, 2019, 14 (12):
  • [26] Preventing type 1 diabetes in late-stage pre-diabetic NOD mice with insulin: A central role for alum as adjuvant
    Martens, Pieter-Jan
    Ellis, Darcy
    Bruggeman, Ylke
    Viaene, Marijke
    Laureys, Jos
    Teyton, Luc
    Mathieu, Chantal
    Gysemans, Conny
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [27] Prevention of the onset of type 1 diabetes in NOD mice by lisofylline
    Yang, ZD
    Chen, M
    Wu, RP
    McDuffie, MJ
    Nadler, JL
    DIABETES, 2001, 50 : A267 - A267
  • [28] Prevention of Type 1 diabetes in NOD mice by helminth infection
    Liu, Qian
    Sundar, Krishnan
    Mousave, Gity
    Bleich, David
    Gause, William
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [29] Interferon alpha initiates type 1 diabetes in NOD mice
    Li, Qing
    Xu, Baohui
    Rubins, Kathleen
    Michie, Sara
    Schreiber, Robert
    McDevitt, Hugh
    CLINICAL IMMUNOLOGY, 2008, 127 : S11 - S11
  • [30] Development of Multivalent Vaccine for Type 1 Diabetes Mellitus (T1DM) in NOD Mice
    Lin, M. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S15 - S15